hba 1c data Search Results


hba 1c  (International Federation of Clinical Chemistry and Laboratory Medicine)
90
International Federation of Clinical Chemistry and Laboratory Medicine hba 1c
Baseline characteristics, by (a) treatment category and (b) educational level, in the Retrospective Epidemiological Study to Investigate Outcome and Mortality with Glucose Lowering Drug Treatment in Primary Care (ROSE) study, 1999–2009
Hba 1c, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hba+1c+data/pmc03654570-57-2-13?v=International+Federation+of+Clinical+Chemistry+and+Laboratory+Medicine
Average 90 stars, based on 1 article reviews
hba 1c - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hba 1c data  (DaVita Labs)
90
DaVita Labs hba 1c data
Hazard ratios, 95% CI , and P ‐trends for the associations between time‐averaged glycated hemoglobin (HbA <t>1c</t> ) and 3 different cardiovascular outcomes (cardiovascular mortality, nonfatal MI , and fatal or nonfatal MI ) from model 4. This model adjusted for end‐stage renal disease incidence; census division (a marker for location); demographic variables such as age, sex, race/ethnicity; Medicare/Medicaid dual eligibility; area‐level geocoded socioeconomic standards variables such as median rent, median household income, percentage living below poverty, percentage unemployed, and percentage with less than high school education; baseline body mass index and estimated glomerular filtration rate; preexisting comorbidities including heart failure, arrhythmias, coronary artery disease, other cardiac disease, peripheral arterial disease, hypertension, chronic obstructive pulmonary disease, current tobacco use, cancer, and alcohol dependence; and laboratory variables such as albumin, normalized protein catabolic rate, hemoglobin, platelet count, white blood cell count, ferritin, mean arterial pressure, pulse pressure, serum calcium, serum phosphorus, parathyroid hormone level, and predialysis weight. For each outcome, <t>HbA</t> <t>1c</t> categories are represented as the following: ᴏ, <6.5% (reference group); +, 6.5% to <7.5%; ×, 7.5% to <8.5%; and Δ, ≥8.5%. CV indicates cardiovascular; MI, myocardial infarction.
Hba 1c Data, supplied by DaVita Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hba+1c+data/pmc05669174-166-2-7?v=DaVita+Labs
Average 90 stars, based on 1 article reviews
hba 1c data - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hba 1c  (Cible Inc)
90
Cible Inc hba 1c
Hazard ratios, 95% CI , and P ‐trends for the associations between time‐averaged glycated hemoglobin (HbA <t>1c</t> ) and 3 different cardiovascular outcomes (cardiovascular mortality, nonfatal MI , and fatal or nonfatal MI ) from model 4. This model adjusted for end‐stage renal disease incidence; census division (a marker for location); demographic variables such as age, sex, race/ethnicity; Medicare/Medicaid dual eligibility; area‐level geocoded socioeconomic standards variables such as median rent, median household income, percentage living below poverty, percentage unemployed, and percentage with less than high school education; baseline body mass index and estimated glomerular filtration rate; preexisting comorbidities including heart failure, arrhythmias, coronary artery disease, other cardiac disease, peripheral arterial disease, hypertension, chronic obstructive pulmonary disease, current tobacco use, cancer, and alcohol dependence; and laboratory variables such as albumin, normalized protein catabolic rate, hemoglobin, platelet count, white blood cell count, ferritin, mean arterial pressure, pulse pressure, serum calcium, serum phosphorus, parathyroid hormone level, and predialysis weight. For each outcome, <t>HbA</t> <t>1c</t> categories are represented as the following: ᴏ, <6.5% (reference group); +, 6.5% to <7.5%; ×, 7.5% to <8.5%; and Δ, ≥8.5%. CV indicates cardiovascular; MI, myocardial infarction.
Hba 1c, supplied by Cible Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hba+1c+data/pmc10120585-130-0-22?v=Cible+Inc
Average 90 stars, based on 1 article reviews
hba 1c - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Baseline characteristics, by (a) treatment category and (b) educational level, in the Retrospective Epidemiological Study to Investigate Outcome and Mortality with Glucose Lowering Drug Treatment in Primary Care (ROSE) study, 1999–2009

Journal: Diabetic Medicine

Article Title: Associations of HbA 1c and educational level with risk of cardiovascular events in 32 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care

doi: 10.1111/dme.12145

Figure Lengend Snippet: Baseline characteristics, by (a) treatment category and (b) educational level, in the Retrospective Epidemiological Study to Investigate Outcome and Mortality with Glucose Lowering Drug Treatment in Primary Care (ROSE) study, 1999–2009

Article Snippet: Data on HbA 1c are also reported in International Federation of Clinical Chemistry (IFCC) units (mmol/mol) Patients were categorized as treated with oral glucose-lowering agents alone or with insulin alone or in combination with oral agents.

Techniques:

Estimated Cox regression, with HbA 1c as annual updated mean as exposure, with age, systolic blood pressure and LDL cholesterol as annual updated mean and gender as covariates. (a) Primary composite endpoint of major cardiovascular events (acute myocardial infarction, heart failure, stroke or cardiovascular death). (b) Cardiovascular death. (c) All-cause mortality.

Journal: Diabetic Medicine

Article Title: Associations of HbA 1c and educational level with risk of cardiovascular events in 32 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care

doi: 10.1111/dme.12145

Figure Lengend Snippet: Estimated Cox regression, with HbA 1c as annual updated mean as exposure, with age, systolic blood pressure and LDL cholesterol as annual updated mean and gender as covariates. (a) Primary composite endpoint of major cardiovascular events (acute myocardial infarction, heart failure, stroke or cardiovascular death). (b) Cardiovascular death. (c) All-cause mortality.

Article Snippet: Data on HbA 1c are also reported in International Federation of Clinical Chemistry (IFCC) units (mmol/mol) Patients were categorized as treated with oral glucose-lowering agents alone or with insulin alone or in combination with oral agents.

Techniques:

Hazard ratios, 95% CI , and P ‐trends for the associations between time‐averaged glycated hemoglobin (HbA 1c ) and 3 different cardiovascular outcomes (cardiovascular mortality, nonfatal MI , and fatal or nonfatal MI ) from model 4. This model adjusted for end‐stage renal disease incidence; census division (a marker for location); demographic variables such as age, sex, race/ethnicity; Medicare/Medicaid dual eligibility; area‐level geocoded socioeconomic standards variables such as median rent, median household income, percentage living below poverty, percentage unemployed, and percentage with less than high school education; baseline body mass index and estimated glomerular filtration rate; preexisting comorbidities including heart failure, arrhythmias, coronary artery disease, other cardiac disease, peripheral arterial disease, hypertension, chronic obstructive pulmonary disease, current tobacco use, cancer, and alcohol dependence; and laboratory variables such as albumin, normalized protein catabolic rate, hemoglobin, platelet count, white blood cell count, ferritin, mean arterial pressure, pulse pressure, serum calcium, serum phosphorus, parathyroid hormone level, and predialysis weight. For each outcome, HbA 1c categories are represented as the following: ᴏ, <6.5% (reference group); +, 6.5% to <7.5%; ×, 7.5% to <8.5%; and Δ, ≥8.5%. CV indicates cardiovascular; MI, myocardial infarction.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus

doi: 10.1161/JAHA.117.005581

Figure Lengend Snippet: Hazard ratios, 95% CI , and P ‐trends for the associations between time‐averaged glycated hemoglobin (HbA 1c ) and 3 different cardiovascular outcomes (cardiovascular mortality, nonfatal MI , and fatal or nonfatal MI ) from model 4. This model adjusted for end‐stage renal disease incidence; census division (a marker for location); demographic variables such as age, sex, race/ethnicity; Medicare/Medicaid dual eligibility; area‐level geocoded socioeconomic standards variables such as median rent, median household income, percentage living below poverty, percentage unemployed, and percentage with less than high school education; baseline body mass index and estimated glomerular filtration rate; preexisting comorbidities including heart failure, arrhythmias, coronary artery disease, other cardiac disease, peripheral arterial disease, hypertension, chronic obstructive pulmonary disease, current tobacco use, cancer, and alcohol dependence; and laboratory variables such as albumin, normalized protein catabolic rate, hemoglobin, platelet count, white blood cell count, ferritin, mean arterial pressure, pulse pressure, serum calcium, serum phosphorus, parathyroid hormone level, and predialysis weight. For each outcome, HbA 1c categories are represented as the following: ᴏ, <6.5% (reference group); +, 6.5% to <7.5%; ×, 7.5% to <8.5%; and Δ, ≥8.5%. CV indicates cardiovascular; MI, myocardial infarction.

Article Snippet: We abstracted HbA 1c data from the DaVita EHR.

Techniques: Marker, Filtration, Cell Counting

Baseline Characteristics of 16 387 US Adult Patients With Diabetes Mellitus Initiating Maintenance Hemodialysis at a DaVita Outpatient Facility <xref ref-type= a , b " width="100%" height="100%">

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus

doi: 10.1161/JAHA.117.005581

Figure Lengend Snippet: Baseline Characteristics of 16 387 US Adult Patients With Diabetes Mellitus Initiating Maintenance Hemodialysis at a DaVita Outpatient Facility a , b

Article Snippet: We abstracted HbA 1c data from the DaVita EHR.

Techniques: Cell Counting

Unadjusted Incidence Rates (per 100 Person‐Years) of Cardiovascular Outcomes According to HbA 1c Categories at Baseline

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus

doi: 10.1161/JAHA.117.005581

Figure Lengend Snippet: Unadjusted Incidence Rates (per 100 Person‐Years) of Cardiovascular Outcomes According to HbA 1c Categories at Baseline

Article Snippet: We abstracted HbA 1c data from the DaVita EHR.

Techniques:

Hazard Ratios (95% CI) of Cardiovascular Outcomes According to HbA 1c Categories

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus

doi: 10.1161/JAHA.117.005581

Figure Lengend Snippet: Hazard Ratios (95% CI) of Cardiovascular Outcomes According to HbA 1c Categories

Article Snippet: We abstracted HbA 1c data from the DaVita EHR.

Techniques: